title: Acute cutaneous T-cell lymphoma transformation during treatment with alemtuzumab.
authors: S
authors: S
authors: Faguer
authors: F
authors: F
authors: Launay
authors: L
authors: L
authors: Ysebaert
authors: C
authors: C
authors: Mailhol
authors: O
authors: O
authors: Estines-Chartier
authors: L
authors: L
authors: Lamant
authors: C
authors: C
authors: Paul
mesh_terms: D000368:Aged; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D018450:Disease Progression; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D008297:Male; D009894:Opportunistic Infections / Q000139:chemically induced; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab